Elanco Animal Health Incorporated (ELAN) |
| 24.51 -0.57 (-2.27%) 08-27 15:59 |
| Open: | 24.91 |
| High: | 25.04 |
| Low: | 24.42 |
| Volume: | 4,093,383 |
| Market Cap: | 12,242(M) |
| PE Ratio: | 23.12 |
| Exchange: | New York Stock Exchange |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 27.98 |
| Resistance 1: | 25.44 |
| Pivot price: | 23.59 |
| Support 1: | 21.32 |
| Support 2: | 17.74 |
| 52w High: | 27.98 |
| 52w Low: | 17.11 |
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
| EPS | -0.410 |
| Book Value | 13.190 |
| PEG Ratio | 4.04 |
| Gross Profit | 5.566 |
| Profit Margin (%) | -3.96 |
| Operating Margin (%) | 8.63 |
| Return on Assets (ttm) | 1.6 |
| Return on Equity (ttm) | -3.0 |
Wed, 26 Aug 2026
Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility - PR Newswire
Tue, 25 Aug 2026
Elanco (NYSE: ELAN) EVP now holds 9,770 deferred units - Stock Titan
Tue, 25 Aug 2026
Elanco (NYSE: ELAN) reports new insider share trade - Stock Titan
Tue, 25 Aug 2026
Elanco (NYSE: ELAN) CFO holds 141.8242 deferred stock units - Stock Titan
Mon, 24 Aug 2026
Elanco Animal Health (ELAN) Stock Analysis: Unlocking a 30% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews
Fri, 21 Aug 2026
Danske Bank A S Makes New $14.35 Million Investment in Elanco Animal Health Incorporated $ELAN - MarketBeat
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |